Qube Research & Technologies Ltd - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 246 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$8,248,760
+49.3%
206,219
+63.9%
0.01%
+44.4%
Q1 2024$5,525,415
+61.2%
125,835
+127.1%
0.01%
+28.6%
Q4 2023$3,426,737
-27.2%
55,404
-45.9%
0.01%
-41.7%
Q3 2023$4,705,881
+1229.9%
102,324
+1561.9%
0.01%
+1100.0%
Q2 2023$353,843
-79.4%
6,157
-90.0%
0.00%
-88.9%
Q4 2022$1,716,813
-25.3%
61,271
-25.1%
0.01%
-35.7%
Q3 2022$2,298,000
+11.5%
81,792
+38.1%
0.01%
-6.7%
Q2 2022$2,061,000
+17.6%
59,233
+21.3%
0.02%0.0%
Q1 2022$1,753,00048,8240.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders